Pictet Asset Management (UK)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pictet Asset Management (UK)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-66,600	Closed	-$2.87M	–	882
2013 Q3	$2.87M	Buy	66,600 +12,000	+22%	+$486K	0.02%	657
2013 Q2	$1.9M	Buy	+54,600	New	+$1.92M	0.01%	727

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Pictet Asset Management (UK)'s XBI Position: Q4 2013 in Review

Pictet Asset Management (UK) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2013, closing a stake of 66,600 shares — an estimated $2.87M sold.

Pictet Asset Management (UK) first reported a position in XBI in Q2 2013 and held it in 2 quarters. The position peaked at $2.87M in Q3 2013. 122 funds tracked by Wall St. Rank hold XBI as of Q4 2013.

Pictet Asset Management (UK) reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2013 after selling out during the quarter.
Pictet Asset Management (UK) sold 66,600 State Street SPDR S&P Biotech ETF shares in Q4 2013, an estimated $2.87M.
Pictet Asset Management (UK) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 2 quarters.
Pictet Asset Management (UK)'s State Street SPDR S&P Biotech ETF position peaked at $2.87M in Q3 2013.
122 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2013.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2013, filed 14 Feb 2014.